Bruce A. Levy, M.D.

Location

Contact

SUMMARY

The clinical and research interests of Bruce A. Levy, M.D., focus on complex knee trauma with a particular emphasis on knee dislocation, multiple ligament knee reconstruction and hip arthroscopy.

Focus areas

• Knee dislocation outcome database. For almost 20 years, Dr. Levy has been collecting prospective patient-reported outcomes (PROs) on patients who dislocate their knees. This database serves as the foundation for numerous publications on variables that affect outcomes in these injuries.
• Hip arthroscopy outcome database. Dr. Levy has been collecting prospective PROs on hip arthroscopy for over 10 years. This database serves as the foundation for numerous publications on variables that affect outcomes in patients with labral tears and femoral acetabular impingement.
• STaR trial. Dr. Levy serves as the principal investigator for this multicenter, randomized clinical trial funded by the Department of Defense studying the effect of early versus delayed multiple ligament knee surgery and rehabilitation.
• MeTeOr trial. Dr. Levy serves as the principal investigator for this multicenter, randomized clinical trial funded by the National Institutes of Health studying the effect of surgery versus physical therapy in patients with meniscal tearing and osteoarthritis. With over 10 years of funding and follow-up data, this study is one the most important landmark research trials ever performed on this topic.
• Stability II trial. Dr. Levy serves as the principal investigator for this multicenter, randomized clinical trial funded by the Canadian Operational Research Society studying the effect of anterior cruciate ligament (ACL) surgery with and without a lateral extra-articular tenodesis — one of the most highly debated topics in ACL surgery.

Significance to patient care

• Mayo's knee dislocation database has been essential in guiding treatment strategies as well as patient and surgeon expectations following surgery for these complex injuries.
• The STaR trial was founded because the U.S. military recognized there was a knowledge gap in the ideal treatment of the multiple ligament injured knee. This study will serve as the landmark study in guiding best strategies to returning troops to active duty and athletes back to their sport.
• The Stability II trial will help guide ideal surgical treatment for patients with ACL disruption and determine whether there is any benefit to an extra-articular tenodesis.
• The MeTeOr Trial has helped change the clinical practice of treating patients with meniscal tear in the setting of osteoarthritis. Over 500,000 knee surgeries are performed for this problem each year in the U.S. Results of this trial have shown that physical therapy is an effective first line of treatment, and if that fails, patients can be treated successfully with surgery.

Professional highlights

• Member, Herodicus Society, 2018-present
• Named to Second Opinion List, National Basketball Association/National Basketball Players Association, 2017-present
• Deputy editor, Sports Medicine section, Clinical Orthopaedics and Related Research, 2012-present
• Editorial board member, The Journal of Knee Surgery, 2010-present
• Editorial board member, Knee Surgery, Sports Traumatology, Arthroscopy, 2010-present
• Editorial board member, Arthroscopy: The Journal of Arthroscopic and Related Surgery, 2009-present
• Director, Mayo Clinic Knee Dislocation Surgical Skills Course, 2007-present
• Board member, Arthroscopy: The Journal of Arthroscopic and Related Surgery, 2011-2016
• Recipient, Award for the best scientific paper at the annual meeting, International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine, 2011
• Clinical Practice Guidelines Committee, American Academy of Orthopaedic Surgeons (AAOS), 2010